Why is Jeevan Scientific Technology Ltd falling/rising?

Strong Short-Term Price Momentum and Market Outperformance

Jeevan Scientific Technology Ltd has demonstrated notable resilience in the short term, with a one-week return of 12.01%, significantly outperforming the Sensex’s 1.59% gain over the same period. Year-to-date, the stock has appreciated by 5.48%, while the Sensex has declined by 1.92%. This positive momentum is further underscored by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling robust technical support and investor confidence.

On 06-Feb, the stock touched an intraday high of Rs 67.99, maintaining a narrow trading range of just Rs 0.01, which suggests a consolidation phase with limited volatility. However, it is important to note that delivery volumes on 05 Feb fell sharply by 43.79% compared to the five-day average, indicating a decline in investor participation despite the price gains. Liquidity remains adequate, with the stock able to support sizeable trade volumes based on recent average traded value.

Long-Term Returns Outpace Market Despite Weak Profitability

Over the past year, Jeevan Scientific Technology Ltd has delivered an impressive 46.56% return, vastly outperforming the BSE500 index’s 7.71% gain. This strong price appreciation contrasts with the company’s fundamental performance, which has been less encouraging. Over five years, the stock’s total return of 13.51% lags behind the Sensex’s 64.75% gain, reflecting challenges in sustaining growth and profitability over the longer term.

Indeed, the company’s operating profits have declined at a steep compound annual growth rate (CAGR) of -204.41% over the last five years, signalling significant operational headwinds. Return on equity (ROE) averages a modest 9.56%, indicating limited profitability relative to shareholders’ funds. These factors highlight a disconnect between the stock’s market performance and its underlying financial health.

Recent Financial Results and Risk Factors

The latest quarterly results for September 2025 reveal further concerns, with a net loss after tax (PAT) of Rs -0.09 crore, representing a sharp decline of 137.5%. The company’s inventory turnover ratio for the half-year stands at a low 18.86 times, and the dividend payout ratio is nil, reflecting a cautious approach to shareholder returns amid financial strain.

Moreover, the stock is considered risky relative to its historical valuations. Despite the strong price gains, profits have fallen by 450% over the past year, underscoring the volatility and uncertainty surrounding the company’s earnings trajectory. Majority shareholding remains with non-institutional investors, which may contribute to less stable trading patterns and investor sentiment.

Balancing Price Gains with Fundamental Caution

In summary, Jeevan Scientific Technology Ltd’s recent stock price rise is driven primarily by strong short-term technical momentum and market outperformance relative to benchmarks. The stock’s consistent gains over the past eight days and its position above key moving averages have attracted investor interest despite a decline in delivery volumes. However, the company’s weak long-term fundamentals, including negative operating profit growth, low profitability ratios, and disappointing recent earnings, suggest caution for investors.

While the stock’s impressive one-year return of 46.56% highlights its potential for capital appreciation, the underlying financial risks and volatile profit performance temper enthusiasm. Investors should weigh the stock’s technical strength against its fundamental challenges when considering exposure to this microcap.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →